OTCMKTS:ALGXYALGAE TEC LTD/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ALGAE TEC LTD/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.0023 0.00 (0.00 %) (As of 06/29/2020) Add Compare Share Today's Range$0.00Now: $0.00▼$0.0050-Day Range N/A52-Week Range$0.00Now: $0.00▼$0.26Volume10 shsAverage Volume1 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta165.87 ProfileAdvanced ChartCompetitorsHeadlinesSocial Media Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for ALGAE TEC LTD/S. Previous Next 2.1 Community Rank Outperform VotesALGAE TEC LTD/S has received 90 “outperform” votes. (Add your “outperform” vote.)Underperform VotesALGAE TEC LTD/S has received 121 “underperform” votes. (Add your “underperform” vote.)Community SentimentALGAE TEC LTD/S has received 57.35% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about ALGAE TEC LTD/S and other stocks. Vote “Outperform” if you believe ALGXY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ALGXY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldALGAE TEC LTD/S does not currently pay a dividend.Dividend GrowthALGAE TEC LTD/S does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ALGAE TEC LTD/S insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.42 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Commercial physical research Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ALGXY Previous Symbol CUSIPN/A CIKN/A Webwww.affinityenergyandhealth.com.au Phone61-8-9380-6790Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.05 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:ALGXY Rates by TradingView Receive ALGXY News and Ratings via Email Sign-up to receive the latest news and ratings for ALGXY and its competitors with MarketBeat's FREE daily newsletter. ALGAE TEC LTD/S (OTCMKTS:ALGXY) Frequently Asked Questions How has ALGAE TEC LTD/S's stock been impacted by COVID-19 (Coronavirus)? ALGAE TEC LTD/S's stock was trading at $0.0017 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALGXY shares have increased by 35.3% and is now trading at $0.0023. View which stocks have been most impacted by Coronavirus. Has ALGAE TEC LTD/S been receiving favorable news coverage? Press coverage about ALGXY stock has trended somewhat negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ALGAE TEC LTD/S earned a daily sentiment score of -1.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news about ALGAE TEC LTD/S. Who are some of ALGAE TEC LTD/S's key competitors? Some companies that are related to ALGAE TEC LTD/S include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), PPD (PPD), Icon (ICLR), Charles River Laboratories Intl. (CRL), Exelixis (EXEL), PRA Health Sciences (PRAH), Syneos Health (SYNH), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Precigen (PGEN), STARPHARMA HOLD/S (SPHRY) and Anavex Life Sciences (AVXL). View all competitors. Who are ALGAE TEC LTD/S's key executives? ALGAE TEC LTD/S's management team includes the following people: Mr. Malcolm Raymond Scott James BBusS, CPA, FAICD, MAusIMM, Exec. Chairman & MD (Age 63)Mr. Garnet Earl McConchie, Exec. Director (Age 68)Mr. James Vosper, Medical Marijuana Consultant What is ALGAE TEC LTD/S's stock symbol? ALGAE TEC LTD/S trades on the OTCMKTS under the ticker symbol "ALGXY." How do I buy shares of ALGAE TEC LTD/S? Shares of ALGXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is ALGAE TEC LTD/S's stock price today? One share of ALGXY stock can currently be purchased for approximately $0.00. What is ALGAE TEC LTD/S's official website? The official website for ALGAE TEC LTD/S is www.affinityenergyandhealth.com.au. How can I contact ALGAE TEC LTD/S? ALGAE TEC LTD/S's mailing address is Unit 2 100 Railway Road, Subiaco C3, 6008. The company can be reached via phone at 61-8-9380-6790. This page was last updated on 7/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
